Induced Pluripotent Stem Cells Generated Without Viral Integration
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Pluripotent stem cells have been generated from mouse and human somatic cells by viral expression of the transcription factors Oct4, Sox2, Klf4, and c-Myc. A major limitation of this technology is the use of potentially harmful genome-integrating viruses. We generated mouse induced pluripotent stem (iPS) cells from fibroblasts and liver cells by using nonintegrating adenoviruses transiently expressing Oct4, Sox2, Klf4, and c-Myc. These adenoviral iPS (adeno-iPS) cells show DNA demethylation characteristic of reprogrammed cells, express endogenous pluripotency genes, form teratomas, and contribute to multiple tissues, including the germ line, in chimeric mice. Our results provide strong evidence that insertional mutagenesis is not required for in vitro reprogramming. Adenoviral reprogramming may provide an improved method for generating and studying patient-specific stem cells and for comparing embryonic stem cells and iPS cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adenovirus and Sendai virus-mediated vector delivery provide alternative non-integrative methods for iPSC reprogramming [24,25,26,27,28].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Self-citationReprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
Dissecting direct reprogramming through integrative genomic analysis
Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., Lander, E. S., & Meissner, A. (2008) · Nature · doi:10.1038/nature07056 · Cited by 1,480
Wernig, M., Zhao, J.-P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Constantine-Paton, M., Isacson, O., & Jaenisch, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801677105 · Cited by 1,216
Research works printed but not linked: 1
- S. Eminli J. Utikal K. Arnold R. Jaenisch K. Hochedlinger Stem Cells published online 17June2008 in press.
Cited by
Items 301–400 of 1,002
Pluripotent Stem Cells as a Potential Tool for Disease Modelling and Cell Therapy in Diabetes
Abdelalim, E. M., Bonnefond, A., Griscelli, A. B., & Froguel, P. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9503-6 · Cited by 77
Human pluripotent stem cells for disease modelling and drug screening
Maury, Y., Gauthier, M., Peschanski, M., & Martinat, C. (2011) · BioEssays · doi:10.1002/bies.201100071 · Cited by 76
Steinle, H., Behring, A., Schlensak, C., Wendel, H. P., & Avci-Adali, M. (2017) · Stem Cells · doi:10.1002/stem.2402 · Cited by 76
Controlling Destiny through Chemistry: Small-Molecule Regulators of Cell Fate
Firestone, A. J., & Chen, J. (2009) · ACS Chemical Biology · doi:10.1021/cb900249y · Cited by 76
Integration-Free iPS Cells Engineered Using Human Artificial Chromosome Vectors
Hiratsuka, M., Uno, N., Ueda, K., Kurosaki, H., Imaoka, N., Kazuki, K., Ueno, E., Akakura, Y., Katoh, M., Osaki, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025961 · Cited by 75
Biodegradable Polymers and Stem Cells for Bioprinting
Lei, M., & Wang, X. (2016) · Molecules · doi:10.3390/molecules21050539 · Cited by 75
Boreström, C., Simonsson, S., Enochson, L., Bigdeli, N., Brantsing, C., Ellerström, C., Hyllner, J., & Lindahl, A. H. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0138 · Cited by 74
Promising New Sources for Pluripotent Stem Cells
Leeb, C., Jurga, M., McGUCKIN, C. P., Moriggl, R., & Kenner, L. (2009) · Stem Cell Reviews and Reports · doi:10.1007/s12015-009-9102-0 · Cited by 74
Cardiac Applications for Human Pluripotent Stem Cells
Shiba, Y., Hauch, K. D., & Laflamme, M. A. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788923804 · Cited by 72
Zheng, Z. S., Jia, J., Zhang, X., Zara, J. N., Yin, W., Chiang, M., Liu, Y., Wang, J., Pang, S., Ting, K., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.049 · Cited by 72
Gene-delivery systems for iPS cell generation
Shao, L., & Wu, W.-S. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903455989 · Cited by 72
Development of stem cell-based therapy for Parkinson’s disease
Han, F., Baremberg, D., Gao, J., Duan, J., Lu, X., Zhang, N., & Chen, Q. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0039-8 · Cited by 72
Bioengineering Organs for Blood Detoxification
Legallais, C., Kim, D., Mihaila, S. M., Mihajlovic, M., Figliuzzi, M., Bonandrini, B., Salerno, S., Yengej, F. A. Y., Rookmaaker, M. B., Romero, N. S., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800430 · Cited by 71
Yamasaki, S., Taguchi, Y., Shimamoto, A., Mukasa, H., Tahara, H., & Okamoto, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087151 · Cited by 71
Retinal pigment epithelium transplantation: concepts, challenges, and future prospects
Alexander, P., Thomson, H. A., Luff, A. J., & Lotery, A. J. (2015) · Eye · doi:10.1038/eye.2015.89 · Cited by 70
Behr, B., Ko, S. H., Wong, V., Gurtner, G. C., & Longaker, M. T. (2010) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181ea42bb · Cited by 70
Embryonic Stem Cells or Induced Pluripotent Stem Cells? A DNA Integrity Perspective
Baï, Q., Desprat, R., Klein, B., Lemaître, J.-M., & Vos, J. D. (2013) · Current Gene Therapy · doi:10.2174/1566523211313020003 · Cited by 70
From “ES-like” cells to induced pluripotent stem cells: A historical perspective in domestic animals
Koh, S., & Piedrahita, J. A. (2013) · Theriogenology · doi:10.1016/j.theriogenology.2013.09.009 · Cited by 70
Restorative approaches in Parkinson's Disease: Which cell type wins the race?
Meyer, A. K., Maisel, M., Hermann, A., Stirl, K., & Storch, A. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.024 · Cited by 70
Lowenthal, J., Lipnick, S., Rao, M., & Hull, S. C. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0029 · Cited by 69
Induced pluripotent stem cells: what lies beyond the paradigm shift
Cox, J. L., & Rizzino, A. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009267 · Cited by 69
Walia, B., Satija, N. K., Tripathi, R. P., & Gangenahalli, G. U. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9279-x · Cited by 69
Stem cell therapy for retinal disease
Tibbetts, M. D., Samuel, M. A., Chang, T. S., & Ho, A. C. (2012) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e328352407d · Cited by 69
Chen, I., Fukuda, K., Fusaki, N., Iida, A., Hasegawa, M., Lichtler, A. C., & Reichenberger, E. (2013) · Cellular Reprogramming · doi:10.1089/cell.2013.0037 · Cited by 69
The Differentiation Stage of Transplanted Stem Cells Modulates Nerve Regeneration
Huang, C.-W., Huang, W., Qiu, X., da Silva, F. F. F., Wang, A., Patel, S. A., Nesti, L. J., Poo, M.-M., & Li, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-17043-4 · Cited by 69
Chen, H., Chuang, C.-Y., Lee, W.-C., Huang, H., Wu, H., Ho, H., Chen, Y., & Kuo, H. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9233-y · Cited by 68
Stem cell-based regenerative opportunities for the liver: State of the art and beyond
Tsolaki, E. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12334 · Cited by 68
Strategies for Whole Lung Tissue Engineering
Calle, E. A., Ghaedi, M., Sundaram, S., Sivarapatna, A., Tseng, M. K., & Niklason, L. E. (2014) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2014.2314261 · Cited by 68
Induced pluripotent stem cells as a new getaway for bone tissue engineering: A systematic review
Bastami, F., Nazeman, P., Moslemi, H., Rad, M. R., Sharifi, K., & Khojasteh, A. (2016) · Cell Proliferation · doi:10.1111/cpr.12321 · Cited by 68
Purified Mesenchymal Stem Cells Are an Efficient Source for iPS Cell Induction
Niibe, K., Kawamura, Y., Araki, D., Morikawa, S., Miura, K., Suzuki, S., Shimmura, S., Sunabori, T., Mabuchi, Y., Nagai, Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017610 · Cited by 67
Li, M., Jayandharan, G. R., Li, B., Ling, C., Ma, W., Srivastava, A., & Zhong, L. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.005 · Cited by 67
Induced Pluripotent Stem Cell Technology in Regenerative Medicine and Biology
Pei, D., Xu, J., Zhuang, Q., Tse, H., & Esteban, M. A. (2010) · Springer eBooks · doi:10.1007/10_2010_72 · Cited by 67
Khan, M. (2024) · Polymers · doi:10.3390/polym16182629 · Cited by 67
Neuronal cell replacement in Parkinson’s disease
Hedlund, E., & Perlmann, T. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02155.x · Cited by 67
The Molecular Mechanism of Induced Pluripotency: A Two-Stage Switch
Scheper, W., & Copray, S. C. V. M. (2009) · Stem Cell Reviews and Reports · doi:10.1007/s12015-009-9077-x · Cited by 67
Preclinical Studies for Induced Pluripotent Stem Cell-based Therapeutics
Harding, J., & Mirochnitchenko, O. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r113.463737 · Cited by 67
New Type of Sendai Virus Vector Provides Transgene-Free iPS Cells Derived from Chimpanzee Blood
Fujie, Y., Fusaki, N., Katayama, T., Hamasaki, M., Soejima, Y., Soga, M., Ban, H., Hasegawa, M., Yamashita, S., Kimura, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113052 · Cited by 67
A practical guide to induced pluripotent stem cell research using patient samples
Santostefano, K. E., Hamazaki, T., Biel, N. M., Jin, S., Umezawa, A., & Terada, N. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.104 · Cited by 66
Human Pluripotent Stem Cell-Derived Cardiomyocytes as Research and Therapeutic Tools
Acimovic, I., Vilotic, A., Pesl, M., Lacampagne, A., Dvorak, P., Rotrekl, V., & Meli, A. C. (2014) · BioMed Research International · doi:10.1155/2014/512831 · Cited by 66
Blazeski, A., Zhu, R., Hunter, D. W., Weinberg, S. H., Zambidis, E. T., & Tung, L. (2012) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2012.07.013 · Cited by 66
An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs
Menon, S., Shailendra, S., Renda, A., Longaker, M. T., & Quarto, N. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010141 · Cited by 66
Vectorology and Factor Delivery in Induced Pluripotent Stem Cell Reprogramming
Hu, K. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0621 · Cited by 66
Enhancing stem cell survival in vivo for tissue repair
Hyun, J. S., Tran, M. C., Wong, V., Chung, M. T., Lo, D. D., Montoro, D. T., Wan, D. C., & Longaker, M. T. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.11.003 · Cited by 66
Upping the Ante: Recent Advances in Direct Reprogramming
Müller, L. U., Daley, G. Q., & Williams, D. A. (2009) · Molecular Therapy · doi:10.1038/mt.2009.72 · Cited by 65
Freund, C. M. A. H., Davis, R. P., Gkatzis, K., Oostwaard, D. W., & Mummery, C. L. (2010) · PubMed Central · Cited by 65
Chemical Strategies for Stem Cell Biology and Regenerative Medicine
Zhu, S., Wei, W., & Ding, S. (2011) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071910-124715 · Cited by 65
RNA-Based Tools for Nuclear Reprogramming and Lineage-Conversion: Towards Clinical Applications
Bernal, J. A. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9494-8 · Cited by 65
The Pharmacology of Regenerative Medicine
Christ, G. J., Saul, J. M., Furth, M. E., & Andersson, K. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007393 · Cited by 65
Illich, D. J., Demir, N., Stojković, M., Scheer, M., Rothamel, D., Neugebauer, J., Hescheler, J., & Zöller, J. E. (2011) · Stem Cells · doi:10.1002/stem.611 · Cited by 65
Induced Tissue-Specific Stem Cells and Epigenetic Memory in Induced Pluripotent Stem Cells
Noguchi, H., Miyagi‐Shiohira, C., & Nakashima, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040930 · Cited by 65
Progress and Promise Towards Safe Induced Pluripotent Stem Cells for Therapy
Seifinejad, A., Tabebordbar, M., Baharvand, H., Boyer, L. A., & Salekdeh, G. H. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9121-x · Cited by 65
Mesenchymal Stromal Cells for Cardiovascular Repair: Current Status and Future Challenges
Mathiasen, A. B., Haack‐Sørensen, M., & Kastrup, J. (2009) · Future Cardiology · doi:10.2217/fca.09.42 · Cited by 64
Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine
Qiao, Y., Agboola, O. S., Hu, X., Wu, Y., & Lei, L. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10042-5 · Cited by 64
Exploring refined conditions for reprogramming cells by recombinant Oct4 protein
Thier, M. C., Mnst, B., & Edenhofer, F. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103193mt · Cited by 64
Stem cell therapy: an exercise in patience and prudence
Lin, H.-T., Otsu, M., & Nakauchi, H. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0334 · Cited by 64
Lee, H. B., Park, J., Forget, B. G., & Gaines, P. C. W. (2009) · Regenerative Medicine · doi:10.2217/rme.09.46 · Cited by 64
Recent developments in transposon-mediated gene therapy
Matteo, M. D., Belay, E., Chuah, M., & VandenDriessche, T. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.684875 · Cited by 64
Using Small Molecules to Improve Generation of Induced Pluripotent Stem Cells from Somatic Cells
Desponts, C., & Ding, S. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-691-7_13 · Cited by 64
The case for induced pluripotent stem cell‐derived cardiomyocytes in pharmacological screening
Khan, J. M., Lyon, A. R., & Harding, S. E. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02118.x · Cited by 63
Multisystem Lewy body disease and the other parkinsonian disorders
Langston, J. W., Schüle, B., Rees, L., Nichols, R. J., & Barlow, C. (2015) · Nature Genetics · doi:10.1038/ng.3454 · Cited by 63
Master Stem Cell Transcription Factors and Signaling Regulation
Li, Y. (2010) · Cellular Reprogramming · doi:10.1089/cell.2009.0033 · Cited by 63
Nauta, A., Larson, B. J., Longaker, M. T., & Lorenz, H. P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-381422-7.10006-9 · Cited by 62
Boué, S., Paramonov, I., Barrero, M. J., & Belmonte, J. C. I. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012664 · Cited by 62
Clinical translation of human iPSC technologies: advances, safety concerns, and future directions
Dhaiban, S., Chandran, S., Noshi, M., & Sajini, A. A. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1627149 · Cited by 62
Amniocytes can serve a dual function as a source of iPS cells and feeder layers
Anchan, R. M., Quaas, P., Gerami‐Naini, B., Bartake, H., Griffin, A., Zhou, Y., Day, D. S., Eaton, J. L., George, L. L., Naber, C. E., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq542 · Cited by 62
Human artificial chromosome-based gene delivery vectors for biomedicine and biotechnology
Kouprina, N., Tomilin, A. N., Masumoto, H., Earnshaw, W. C., & Larionov, V. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.882314 · Cited by 62
X-Chromosome Inactivation in Rett Syndrome Human Induced Pluripotent Stem Cells
Cheung, A. Y. L., Horvath, L. M., Carrel, L., & Ellis, J. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00024 · Cited by 61
Mechanistic insights into reprogramming to induced pluripotency
Ho, R., Chronis, C., & Plath, K. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22450 · Cited by 61
Trosko, J. E., & Chang, C. (2009) · Toxicology · doi:10.1016/j.tox.2009.11.019 · Cited by 61
Induced Pluripotent Stem Cells: Next Generation Cells for Tissue Regeneration
Ibrahim, A. Y., Mehdi, M. Q., Abbas, A. O., Alashkar, A. H., & Haider, K. H. (2016) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2016.94017 · Cited by 61
Design and potential of non-integrating lentiviral vectors
Shaw, A., & Cornetta, K. (2014) · Biomedicines · doi:10.3390/biomedicines2010014 · Cited by 60
Clinical Therapy Using iPSCs: Hopes and Challenges
Lu, X., & Zhao, T. (2013) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2013.09.002 · Cited by 60
Tavernier, G., Wolfrum, K., Demeester, J., Smedt, S. C. D., Adjaye, J., & Rejman, J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.062 · Cited by 60
Hossain, M. K., Dayem, A. A., Han, J., Saha, S. K., Yang, G., Choi, H. Y., & Cho, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020256 · Cited by 60
Raya, Á., Rodríguez-Pizà, I., Navarro, S., Richaud‐Patín, Y., Güenechea, G., Sánchez‐Danés, A., Consiglio, A., Bueren, J. A., & Belmonte, J. C. I. (2010) · Nature Protocols · doi:10.1038/nprot.2010.9 · Cited by 60
Vascular microphysiological systems to model diseases
Zhang, Q., Zhang, X., & Truskey, G. A. (2020) · Cell and Gene Therapy Insights · doi:10.18609/cgti.2020.012 · Cited by 60
The genetics of induced pluripotency
Ralston, A., & Rossant, J. (2010) · Reproduction · doi:10.1530/rep-09-0024 · Cited by 60
Löhle, M., Hermann, A., Glaß, H., Kempe, A., Schwarz, S. C., Kim, J. B., Poulet, C. E., Ravens, U., Schwarz, J., Schöler, H. R., et al. (2012) · Stem Cells · doi:10.1002/stem.1016 · Cited by 60
Martins, A. M., Vunjak-Novakovic, G., & Reis, R. L. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9487-7 · Cited by 59
2A to the Fore – Research, Technology and Applications
Luke, G. A., Escuin-Ordinas, H., de Felipe, P., & Ryan, M. D. (2009) · Biotechnology and Genetic Engineering Reviews · doi:10.5661/bger-26-223 · Cited by 59
Converting human pluripotent stem cells into β-cells: recent advances and future challenges
Mayhew, C. N., & Wells, J. M. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283337e1c · Cited by 59
How induced pluripotent stem cells are redefining personalized medicine
Ferreira, L. M. R., & Mostajo-Radji, M. A. (2013) · Gene · doi:10.1016/j.gene.2013.02.037 · Cited by 59
Stem cells as a potential therapy for epilepsy
Roper, S. N., & Steindler, D. A. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.004 · Cited by 59
Reprogramming human fibroblasts using HIV-1 TAT recombinant proteins OCT4, SOX2, KLF4 and c-MYC
Pan, C., Lu, B., Chen, H., & Bishop, C. E. (2009) · Molecular Biology Reports · doi:10.1007/s11033-009-9680-6 · Cited by 59
Revilla, A., González, C., Iriondo, A., Fernández, B., Prieto, C., Marín, C., & Liste, I. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2021 · Cited by 59
Autologous blood cell therapies from pluripotent stem cells
Lengerke, C., & Daley, G. Q. (2009) · Blood Reviews · doi:10.1016/j.blre.2009.10.001 · Cited by 59
Regenerating functional heart tissue for myocardial repair
Alcon, A., Çağavi, E., & Qyang, Y. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0942-4 · Cited by 59
Safeguarding Nonhuman Primate iPS Cells With Suicide Genes
Zhong, B., Watts, K. L., Gori, J. L., Wohlfahrt, M. E., Enssle, J., Adair, J. E., & Kiem, H. (2011) · Molecular Therapy · doi:10.1038/mt.2011.51 · Cited by 59
Kleger, A., Mahaddalkar, P. U., Katz, S., Lechel, A., Joo, J. Y., Loya, K., Lin, Q., Hartmann, D., Liebau, S., Kraus, J. M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.004 · Cited by 58
High-content screening of primary neurons: ready for prime time
Daub, A. C., Sharma, P., & Finkbeiner, S. M. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.10.002 · Cited by 58
Lach, M., Rosochowicz, M. A., Richter, M., Jagiełło, I., Suchorska, W. M., & Trzeciak, T. (2022) · Cells · doi:10.3390/cells11030529 · Cited by 58
The immune boundaries for stem cell based therapies: problems and prospective solutions
Hmadcha, A., Juan, D., Wakeman, J. A., Mohamed, A., & Soria, B. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00837.x · Cited by 58
The many ways to make an iPS cell
Lowry, W. E., & Plath, K. (2008) · Nature Biotechnology · doi:10.1038/nbt1108-1246 · Cited by 58
Treating Parkinson's disease in the 21st century: Can stem cell transplantation compete?
Buttery, P. C., & Barker, R. A. (2014) · The Journal of Comparative Neurology · doi:10.1002/cne.23577 · Cited by 58
Cell Transplantation and Gene Therapy in Parkinson's Disease
Wakeman, D. R., Dodiya, H. B., & Kordower, J. H. (2011) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20233 · Cited by 58
Brennand, K. J., Landek-Salgado, M. A., & Sawa, A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.025 · Cited by 57
Small Molecules that Promote Self-Renewal of Stem Cells and Somatic Cell Reprogramming
Chen, G., Guo, Y., Li, C., Li, S., & Wan, X. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-09965-w · Cited by 57
Pluripotent Stem Cells and Reprogrammed Cells in Farm Animals
Nowak‐Imialek, M., Kues, W. A., Carnwath, J. W., & Niemann, H. (2011) · Microscopy and Microanalysis · doi:10.1017/s1431927611000080 · Cited by 57
Li, J., Song, W., Pan, G., & Zhou, J. (2014) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0050-z · Cited by 57
How microRNAs facilitate reprogramming to pluripotency
Anokye‐Danso, F., Snitow, M. E., & Morrisey, E. E. (2012) · Journal of Cell Science · doi:10.1242/jcs.095968 · Cited by 57
Metadata
- Authors
- Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- Hochedlinger, Konrad
- Venue
- Science
- Published
- 2008-11-07
- Volume
- 322
- Issue
- 5903
- Pages
- 945-949
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3987909
- OpenAlex
- W2050689355
- Cited by
- 1,683
- References
- 29
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 33 · 2023: 22 · 2022: 32 · 2021: 55 · 2020: 50 · 2019: 38 · 2018: 63 · 2017: 63 · 2016: 104 · 2015: 105 · 2014: 139 · 2013: 161 · 2012: 185
- FWCI
- 82.28
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1dp2od003266-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- induced pluripotent stem cells, Oct4, SOX2, KLF4, c-Myc, somatic cell reprogramming, DNA demethylation, teratoma, chimeric mice, fibroblasts, hepatocytes, insertional mutagenesis, patient-derived stem cells, embryonic stem cells
- MeSH terms
- Kruppel-Like Factor 4, Adenoviridae, Animals, Cell Differentiation, Cell Line, Chimera, Cloning, Molecular, Female, Fibroblasts, Genetic Vectors, Liver, Male, Teratoma, Genes, myc, Proto-Oncogene Proteins c-myc, Mice, SCID, Virus Integration, Transgenes, Hepatocytes, Pluripotent Stem Cells, Octamer Transcription Factor-3, Mice, Kruppel-Like Transcription Factors, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.